Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards.

With one of the longest track records of the API industry, having deep development expertise and a broad set of advanced technologies, we are the partner of choice which enables our client’s molecules to enter the market successfully.

Olon has a global network of 14 manufacturing sites and 9 R&D centers across the globe. Thanks to our 2,800 employees, including over 350 highly experienced and qualified R&D experts, we represent a highly innovative and reliable partner.

At Olon, expertise and competent flexibility throughout the organization help build successful outcomes for our clients in custom chemical synthesis and biological processes, while always maintaining the highest levels of safety, quality, and environmental compliance.